Patrick Amstutz

Title: The Innovations of Patrick Amstutz

Introduction

Patrick Amstutz is a notable inventor based in Kilchberg, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of binding proteins that have implications for treating coronavirus diseases.

Latest Patents

Amstutz holds a patent for "Ankyrin repeat binding proteins and their uses." This invention relates to recombinant binding proteins that comprise one or more designed ankyrin repeat domains with binding specificity for coronavirus spike proteins. The patent also covers nucleic acids encoding such proteins, pharmaceutical compositions that include these proteins or nucleic acids, and their use in treating diseases caused by SARS-CoV-2.

Career Highlights

Patrick Amstutz is associated with Molecular Partners AG, a company that focuses on developing innovative therapies based on its proprietary protein engineering technology. His work has been pivotal in advancing therapeutic options for viral infections, particularly in the context of the ongoing global health challenges posed by coronaviruses.

Collaborations

Some of his notable coworkers include Valerie Perrine Calabro and Marcel Walser, who have collaborated with him on various projects within the company.

Conclusion

Patrick Amstutz's contributions to biotechnology, particularly through his patent on ankyrin repeat binding proteins, highlight his role as an innovator in the fight against coronavirus diseases. His work continues to influence the development of effective treatments in this critical area of health.